The Pharmaceutical Industry and the Fight Against Doping

28 January 2015 - Tokyo,Japan

Reporting FILM

Second International Conference: The Pharmaceutical Industry and the Fight Against Doping in Sport - Tokyo, Japan

2nd International Conference for pharmaceutical industry and anti-doping for public health - 2015 Tokyo Conference, 2015.1.28 The event was attended by more than 300 representatives from leading organisations in the anti-doping, sport and pharmaceutical industries who explored new ways to help protect the rights of the clean athlete and restrict the abuse of licensed and unlicensed medicines.

The Conference has led to the latest step in increased cooperation between the anti-doping and pharmaceutical industries; and, aimed to further improve information sharing and collaboration to tackle the issue of doping within sport and society as a whole.

Short Version (1min snap shot)

Full version

outline

Second International Conference on The Pharmaceutical Industry and the Fight Against Doping: New Developments for Clean Sport and Society

The pharmaceutical and anti-doping communities met in Tokyo on Wednesday 28 January 2015 for the Second International Conference on the Pharmaceutical Industry and the Fight against Doping: New Developments for Clean Sport and Society.

The Conference - which follows on from the ground-breaking inaugural event in Paris in November 2012 - saw representatives from across the pharmaceutical and anti-doping communities convene to explore ways to help protect the rights of clean athletes and to restrict the abuse of licensed and unlicensed medicines.

The Conference was co-hosted by the World Anti-Doping Agency (WADA), the Ministry of Education, Culture, Sports, Science and Technology of Japanese Government (MEXT), the Japan Anti-Doping Agency (JADA) and UNSECO. A number of topics were discussed, including:

  • Societal and economic risks of doping
  • Challenges in anti-doping and the role of the Biopharmaceutical Industry
  • Collaborative perspectives for the Biopharmaceutical Industry and anti-doping authorities in the future